Use of sulfonamide carbonic anhydrase inhibitors in treatment of meningococcal carriers: rationale and report of a clinical trial of ethoxzolamide.
D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D002353:Carrier State / Q000188:drug therapy*; D006801:Humans; D066298:In Vitro Techniques; D008589:Meningococcal Infections / Q000188:drug therapy*; D009345:Neisseria meningitidis / Q000187:drug effects; D013411:Sulfadiazine / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology
D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D013411:Sulfadiazine